Grifols, S.A.
Status: Publicly traded
Direct answer
Grifols, S.A. is publicly traded on NASDAQ under the ticker GRFS.
Grifols, S.A., a company founded in 1940 and headquartered in Barcelona, Spain, specializes in the development, manufacture, and distribution of therapeutic products, with a primary focus on those derived from human plasma. Its operations are organized into several divisions. The Bioscience division is dedicated to researching, producing, and marketing plasma-derived medicines, such as immunoglobulins, alpha-1...
Can you invest in Grifols, S.A.?
Yes. Grifols, S.A. is publicly traded on NASDAQ under the ticker GRFS.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Grifols, S.A.
Detailed equity research is provided by MarketSnap.